2B70:F:F-iShares NASDAQ US Biotechnology UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.922

Change

-0.09 (-1.42)%

Market Cap

USD 0.52B

Volume

4.31K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

ETFs Containing 2B70:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.93% 43% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.93% 41% F 47% F
Trailing 12 Months  
Capital Gain 6.24% 45% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.24% 42% F 49% F
Trailing 5 Years  
Capital Gain 42.89% 62% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.89% 61% D- 51% F
Average Annual (5 Year Horizon)  
Capital Gain 6.44% 68% D+ 67% D+
Dividend Return 6.44% 67% D+ 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.60% 41% F 72% C
Risk Adjusted Return 44.11% 65% D 71% C-
Market Capitalization 0.52B 62% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.